Elderly population needs new definition to inform treatment decisions
Elderly population needs new definition to inform treatment decisions
Expert care is needed for elderly haematology patients
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer
Engineering of polymeric nanoparticles for medical applications
ecancerNews November Round Up
Editor’s Choice - ecancermedicalscience November 2013
The future of CLL treatment: balancing efficacy, safety and cost
Making sense of the expanding armoury of treatment options for the less fit CLL patient
‘Go-Go’ CLL patients: a look towards the future
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer
Chemosaturation therapy for cancers in the liver